Diabetics who seek to aggressively lower their blood pressure and cholesterol are not reducing their risk of a heart attack and could suffer negative side effects, a study released Sunday said. The results of the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial appear to repudiate years of medical advice for type-2 diabetics who face a high ...

ATLANTA (Reuters) - Adding a triglyceride-lowering drug to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study. The study run by the National Institutes of Health, dubbed Accord, aimed to see if the dual-drug therapy could reduce cardiovascular events in diabetes patients ...

Too much cancer screening, too many heart tests, too many cesarean sections. A spate of recent reports suggests that many Americans are being overtreated. Maybe even President Barack Obama, champion of an overhaul and cost-cutting of the health care system. Is it doctors practicing defensive medicine? Or are ...

WASHINGTON (Reuters) - Two studies published on Wednesday show it is possible to sequence the entire gene maps of families with inherited diseases and pinpoint the offending bit of DNA. The studies, which would not have been possible a year or two ago, are the first real delivery of the promised transformation of medical science from the Human Genome Project's ...